Mass General Brigham President and CEO Anne Klibanski, MD, shared a muted reaction to longtime affiliate Dana-Farber Cancer Institute's decision to partner with another Boston health system for cancer care in a recent op-ed with the Boston Globe. On Sept. 14, Dana-Farber and Beth Israel ...
Mass General Brigham is a world-leading eco-system for GCT research and clinical trials, with over 400 researchers working on ground-breaking gene and cell therapy research and treatment in pursuit of potential cures. Hitachi has a strong track...
Corresponding Author: Shalender Bhasin, MB, BS, Research Program in Men’s Health: Aging and Metabolism, Boston Claude D. Pepper Older Americans Independence Center for Function Promoting Therapies, Brigham and Women’s Hospital, 221 Longwood Ave, Boston, MA 02115 (sbhasin@partners.org). Publish...
Department of Medicine, Channing Laboratory, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA Lu Qi, Frank B Hu & David J Hunter Institute of Epidemiology, Helmholtz Zentrum München-German Research Center for Environmental Health, Neuherberg, Germany Iris M Heid...
first. death of a participant was confirmed using the national death index. informed consent from study participants was indicated if the follow-up questionnaires were returned. the study was approved by the human subjects committees at harvard school of public health and brigham and women's ...
Imperial College Healthcare NHS Trust, London, UK John C. Chambers & Jaspal S. Kooner Division of Genetics, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA Daniel I. Chasman Division of Preventive Medicine, Brigham and Women’s Hospital and Harvard Medical School, ...
Massachusetts General Hospital, University Medical Center Groningen, Leiden University Medical Center, Erasmus MC - University Medical Center Rotterdam, University Medicine Greifswald, Brigham and Women’s Hospital, ethics committee northwest/central Switzerland, ethics committee Zurich, Pirkanmaa Hospital Distric...
there is a progressive loss of skeletal muscle mass, and a concurrent increase in fatty infiltration and fibrosis of muscle. This loss of muscle mass may reach a critical point at which time functional impairment and even disability occurs8. In fact, the annual healthcare costs of sarcopenia in...
Regional Center for Neurosensory Disorders, School of Dentistry, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA Luda Diatchenko & William Maixner Department of General Practice and Primary Health Care, University of Helsinki, Helsinki, 00014, Finland ...
Over the past six years, researchers have been working with industry and other stakeholders to develop and commercialize healthcare AI algorithms, efforts which became more formalized within the last year. Dreyer noted that as of December, most of Mass General Brigham’s AI algor...